Hepion Pharmaceuticals Inc (HEPA) — Cash Flow Quality Index
Latest as of June 2017:
-2.07x
Hepion Pharmaceuticals Inc (HEPA) has a Cash Flow Quality Index of -2.07x as of June 2017. Operating cash flow of $-4.25 Million is below net income of $2.05 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Hepion Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-2.07x
Operating CF / Net Income
Operating Cash Flow
$-4.25 Million
USD
Net Income
$2.05 Million
USD
Data as of
Jun 2017
Most recent filing
Annual Cash Flow Quality Index for Hepion Pharmaceuticals Inc (None–None)
Year-by-year earnings quality comparison for Hepion Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.